Your browser doesn't support javascript.
loading
Reversible vancomycin susceptibility within emerging ST1421 Enterococcus faecium strains is associated with rearranged vanA-gene clusters and increased vanA plasmid copy number.
Wagner, Theresa Maria; Janice, Jessin; Schulz, Mark; Ballard, Susan A; da Silva, Anders Goncalves; Coombs, Geoffrey W; Daley, Denise A; Pang, Stanley; Mowlaboccus, Shakeel; Stinear, Tim; Hegstad, Kristin; Howden, Benjamin P; Sundsfjord, Arnfinn.
Affiliation
  • Wagner TM; Research group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Janice J; Research group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospit
  • Schulz M; The Microbiological Diagnostic Unit Public Health Laboratory and Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, University of Melbourne, Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
  • Ballard SA; The Microbiological Diagnostic Unit Public Health Laboratory and Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, University of Melbourne, Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
  • da Silva AG; The Microbiological Diagnostic Unit Public Health Laboratory and Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, University of Melbourne, Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
  • Coombs GW; Antimicrobial Resistance and Infectious Disease (AMRID) Research Laboratory, Murdoch University, Murdoch, Western Australia, Australia; Department of Microbiology, PathWest Laboratory Medicine-WA, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Daley DA; Australian Group on Antimicrobial Resistance, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Pang S; Antimicrobial Resistance and Infectious Disease (AMRID) Research Laboratory, Murdoch University, Murdoch, Western Australia, Australia; Department of Microbiology, PathWest Laboratory Medicine-WA, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Mowlaboccus S; Antimicrobial Resistance and Infectious Disease (AMRID) Research Laboratory, Murdoch University, Murdoch, Western Australia, Australia; Department of Microbiology, PathWest Laboratory Medicine-WA, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Stinear T; The Microbiological Diagnostic Unit Public Health Laboratory and Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, University of Melbourne, Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
  • Hegstad K; Research group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospit
  • Howden BP; The Microbiological Diagnostic Unit Public Health Laboratory and Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, University of Melbourne, Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Department of Infectious Diseases, Austin Health
  • Sundsfjord A; Research group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospit
Int J Antimicrob Agents ; 62(1): 106849, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37187337

Full text: 1 Database: MEDLINE Main subject: Gram-Positive Bacterial Infections / Enterococcus faecium Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Oceania Language: En Journal: Int J Antimicrob Agents Year: 2023 Type: Article Affiliation country: Norway

Full text: 1 Database: MEDLINE Main subject: Gram-Positive Bacterial Infections / Enterococcus faecium Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Oceania Language: En Journal: Int J Antimicrob Agents Year: 2023 Type: Article Affiliation country: Norway